Characterization of gliclazide-polyethylene glycol solid dispersion and its effect on dissolution

Brazilian Journal of Pharmaceutical Sciences

Volumn 47, Issue 1, 2011, Pages 161-166

  Patil, Moreshwar Pandharinath ^a   Gaikwad, Naresh Janardan ^b  

^a T V E S's Hon'ble LMC College of Pharmacy   (India)

^b RTM NAGPUR UNIVERSITY   (India)

Author keywords

Gliclazide; In vitro dissolution; Polyethylene glycol 6000; Solid dispersion

Indexed keywords

GLICLAZIDE; MACROGOL 6000;

ARTICLE; CONTROLLED STUDY; CRYSTALLITE SIZE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STRUCTURE; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; SOLID DISPERSION; WETTABILITY; X RAY DIFFRACTION;

EID: 79957575895     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502011000100020     Document Type: Article

References (15)

1. CHIOU, W. L.; RIEGELMAN, S. Pharmaceutical applications of solid dispersions. J. Pharm. Sci., v.60, p.1281-1302, 1971.
2. CHOWDARY, K. P. R.; MURTHY, K. V. R.; PRASAD, C. D. S. Solid dispersions of nimodipine: physico-chemical and dissolution rate studies. Indian Drugs, v.32, p.537-542, 1995.
3. DESAI, K. G.; LIU, C. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions. Pharm. Dev. Technol., v.10, n.4, p.467-477, 2005.
4. FORD, J. L.; ROBENSTEIN, H. The current status of solid dispersions. Pharm. Acta Helv., v.61, p.69-87, 1986.
5. GILLMAN, A. G.; RALL, T. W.; NIES, A. S.; TAYLOR, P. Goodman and Gillman's the pharmacological basis of therapeutics. 8. ed. New York: Maxwell House, 1990. p.1485-1486.
6. KERC, J.; SRCIC, S.; KOFLER, B. Alternative solvent-free preparation methods for felodipine surface solid dispersions. Drug Dev. Ind. Pharm., v.24, p.359-363, 1998.
7. LEUNER, C.; DRESSMAN, J. Improving drug solubility for oral delivery using solid dispersions. Eur J. Pharm. Biopharm., v.50, p.47-60, 2000.
8. MAILHOT, J. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian mul-ticenter study. Clin. Ther., v.15, p.1060-1068, 1993.
9. OZKAN, Y.; DOGANAY, N.; DIKMEN, N.; ISIMER, A. Enhanced release of solid dispersion of etodolac in polyethylene glycol. Farmaco, v.55, n.6/7, p.433-438, 2000.
10. PALMER, K. J.; BROGDEN, R. N. Gliclazide: an update of its pharmacological properties and therapeutic efficacy in non insulin-dependent diabetes mellitus. Drugs, v.46, p.92-125, 1993.
11. SEKIGUCHI, K.; OBI, N. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixture of sulphathiazole and that of ordinary sulphathiazole in man. Chem. Pharm. Bull., v.9, p.866-872, 1961.
12. SHAH, T.J.; AMIN, A.F.; PARIKH, J.R.; PARIKH, R.H. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug, AAPS PharmaScitech., Virginia, v.8(2), p. E1-E7, 2007.
13. TACHIBANA, T.; NAKAMURA, A. A method for preparing an aqueous colloidal dispersion of organic material by using water soluble polymers: dispersion of beta-carotene by polyvinylpyrrolidone. Colloid Polym. Sci., v.203, n.2, p.130-133, 1965.
14. TESSIER, D.; DAWSON, K.; TETRAULT, J. P.; BRAVO, G.; MENEILLY, G. S. Glibenclamide vs gliclazide in type II diabetes of the elderly. Diabet. Med., v.11, p.974-980, 1994.
15. UNITED States Pharmacopoeia. 24. ed. Rockville: United States Pharmacopoeial Convention, 2000. p.1941-1944.